Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd569fbfa1953ca9b7b375510e4d2763 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737 |
filingDate |
1999-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_777106ecbe2b3803de1089eb39dcc964 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5439af60c01b7e21179a6f68b2caa4eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_025c4c906f5910c43b9a70dd60b9ef38 |
publicationDate |
2000-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2000309537-A |
titleOfInvention |
Intestinal disease preventive and / or therapeutic agent |
abstract |
(57) [Problem] To provide a drug utilizing a new pharmacological action of sulfated glycosaminoglycan. SOLUTION: The prophylactic and / or therapeutic agent for intestinal disease containing sulfated glycosaminoglycan or a pharmaceutically acceptable salt thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-011386-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7655260-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100444744-C http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005011400-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100786174-B1 |
priorityDate |
1999-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |